203 related articles for article (PubMed ID: 20384997)
1. Tubulin binding cofactor C (TBCC) suppresses tumor growth and enhances chemosensitivity in human breast cancer cells.
Hage-Sleiman R; Herveau S; Matera EL; Laurier JF; Dumontet C
BMC Cancer; 2010 Apr; 10():135. PubMed ID: 20384997
[TBL] [Abstract][Full Text] [Related]
2. Silencing of tubulin binding cofactor C modifies microtubule dynamics and cell cycle distribution and enhances sensitivity to gemcitabine in breast cancer cells.
Hage-Sleiman R; Herveau S; Matera EL; Laurier JF; Dumontet C
Mol Cancer Ther; 2011 Feb; 10(2):303-12. PubMed ID: 21216936
[TBL] [Abstract][Full Text] [Related]
3. Griseofulvin stabilizes microtubule dynamics, activates p53 and inhibits the proliferation of MCF-7 cells synergistically with vinblastine.
Rathinasamy K; Jindal B; Asthana J; Singh P; Balaji PV; Panda D
BMC Cancer; 2010 May; 10():213. PubMed ID: 20482847
[TBL] [Abstract][Full Text] [Related]
4. βIII-tubulin enhances efficacy of cabazitaxel as compared with docetaxel.
Smiyun G; Azarenko O; Miller H; Rifkind A; LaPointe NE; Wilson L; Jordan MA
Cancer Chemother Pharmacol; 2017 Jul; 80(1):151-164. PubMed ID: 28567478
[TBL] [Abstract][Full Text] [Related]
5. Effect of stathmin on the sensitivity to antimicrotubule drugs in human breast cancer.
Alli E; Bash-Babula J; Yang JM; Hait WN
Cancer Res; 2002 Dec; 62(23):6864-9. PubMed ID: 12460900
[TBL] [Abstract][Full Text] [Related]
6. An antitubulin agent BCFMT inhibits proliferation of cancer cells and induces cell death by inhibiting microtubule dynamics.
Rai A; Surolia A; Panda D
PLoS One; 2012; 7(8):e44311. PubMed ID: 22952952
[TBL] [Abstract][Full Text] [Related]
7. 2-Methoxyestradiol suppresses microtubule dynamics and arrests mitosis without depolymerizing microtubules.
Kamath K; Okouneva T; Larson G; Panda D; Wilson L; Jordan MA
Mol Cancer Ther; 2006 Sep; 5(9):2225-33. PubMed ID: 16985056
[TBL] [Abstract][Full Text] [Related]
8. Role of cofactors B (TBCB) and E (TBCE) in tubulin heterodimer dissociation.
Kortazar D; Fanarraga ML; Carranza G; Bellido J; Villegas JC; Avila J; Zabala JC
Exp Cell Res; 2007 Feb; 313(3):425-36. PubMed ID: 17184771
[TBL] [Abstract][Full Text] [Related]
9. Mechanism of action of ixabepilone and its interactions with the βIII-tubulin isotype.
Lopus M; Smiyun G; Miller H; Oroudjev E; Wilson L; Jordan MA
Cancer Chemother Pharmacol; 2015 Nov; 76(5):1013-24. PubMed ID: 26416565
[TBL] [Abstract][Full Text] [Related]
10. ADP ribosylation factor like 2 (Arl2) protein influences microtubule dynamics in breast cancer cells.
Beghin A; Honore S; Messana C; Matera EL; Aim J; Burlinchon S; Braguer D; Dumontet C
Exp Cell Res; 2007 Feb; 313(3):473-85. PubMed ID: 17188265
[TBL] [Abstract][Full Text] [Related]
11. CKT0353, a novel microtubule targeting agent, overcomes paclitaxel induced resistance in cancer cells.
Dinić J; Ríos-Luci C; Karpaviciene I; Cikotiene I; Fernandes MX; Pešić M; Padrón JM
Invest New Drugs; 2020 Jun; 38(3):584-598. PubMed ID: 31177401
[TBL] [Abstract][Full Text] [Related]
12. Arsenic trioxide produces polymerization of microtubules and mitotic arrest before apoptosis in human tumor cell lines.
Ling YH; Jiang JD; Holland JF; Perez-Soler R
Mol Pharmacol; 2002 Sep; 62(3):529-38. PubMed ID: 12181429
[TBL] [Abstract][Full Text] [Related]
13. Estradiol dimer inhibits tubulin polymerization and microtubule dynamics.
Jurášek M; Černohorská M; Řehulka J; Spiwok V; Sulimenko T; Dráberová E; Darmostuk M; Gurská S; Frydrych I; Buriánová R; Ruml T; Hajdúch M; Bartůněk P; Dráber P; Džubák P; Drašar PB; Sedlák D
J Steroid Biochem Mol Biol; 2018 Oct; 183():68-79. PubMed ID: 29803726
[TBL] [Abstract][Full Text] [Related]
14. Synthesis and Preclinical Evaluation of Indole Triazole Conjugates as Microtubule Targeting Agents that are Effective against MCF-7 Breast Cancer Cell Lines.
Yele V; Pindiprolu SKSS; Sana S; Ramamurty DSVNM; Madasi JRK; Vadlamani S
Anticancer Agents Med Chem; 2021; 21(8):1047-1055. PubMed ID: 32981511
[TBL] [Abstract][Full Text] [Related]
15. Slug increases sensitivity to tubulin-binding agents via the downregulation of βIII and βIVa-tubulin in lung cancer cells.
Tamura D; Arao T; Nagai T; Kaneda H; Aomatsu K; Fujita Y; Matsumoto K; De Velasco MA; Kato H; Hayashi H; Yoshida S; Kimura H; Maniwa Y; Nishio W; Sakai Y; Ohbayashi C; Kotani Y; Nishimura Y; Nishio K
Cancer Med; 2013 Apr; 2(2):144-54. PubMed ID: 23634282
[TBL] [Abstract][Full Text] [Related]
16. Natural product derivative Bis(4-fluorobenzyl)trisulfide inhibits tumor growth by modification of beta-tubulin at Cys 12 and suppression of microtubule dynamics.
Xu W; Xi B; Wu J; An H; Zhu J; Abassi Y; Feinstein SC; Gaylord M; Geng B; Yan H; Fan W; Sui M; Wang X; Xu X
Mol Cancer Ther; 2009 Dec; 8(12):3318-30. PubMed ID: 19996274
[TBL] [Abstract][Full Text] [Related]
17. MicroRNA-1251-5p Promotes Carcinogenesis and Autophagy via Targeting the Tumor Suppressor TBCC in Ovarian Cancer Cells.
Shao Y; Liu X; Meng J; Zhang X; Ma Z; Yang G
Mol Ther; 2019 Sep; 27(9):1653-1664. PubMed ID: 31278033
[TBL] [Abstract][Full Text] [Related]
18. Microtubule dynamics, mitotic arrest, and apoptosis: drug-induced differential effects of betaIII-tubulin.
Gan PP; McCarroll JA; Po'uha ST; Kamath K; Jordan MA; Kavallaris M
Mol Cancer Ther; 2010 May; 9(5):1339-48. PubMed ID: 20442307
[TBL] [Abstract][Full Text] [Related]
19. Antiproliferative Activity of Crocin Involves Targeting of Microtubules in Breast Cancer Cells.
Hire RR; Srivastava S; Davis MB; Kumar Konreddy A; Panda D
Sci Rep; 2017 Mar; 7():44984. PubMed ID: 28337976
[TBL] [Abstract][Full Text] [Related]
20. Anti-STMN1 therapy improves sensitivity to antimicrotubule drugs in esophageal squamous cell carcinoma.
Wang S; Akhtar J; Wang Z
Tumour Biol; 2015 Sep; 36(10):7797-806. PubMed ID: 25944168
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
